Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Blood
|
August 26, 2004
Dynamic regulation of IL-7 receptor expression is required for normal thymopoiesis
Ivana Munitic, Joy A Williams, Yili Yang, et al.
International Immunology
|
August 18, 2012
High levels of IL-7 cause dysregulation of thymocyte development
Nahed El-Kassar, Francis A Flomerfelt, Baishakhi Choudhury, et al.
Transfusion
|
October 7, 2024
Analysis of bleeding outcomes in patients with hypoproliferative thrombocytopenia in the A-TREAT clinical trial
Jacqueline N Poston, Siobhan P Brown, Amy Sarah Ginsburg, et al.
Blood
|
May 25, 2004
A dose effect of IL-7 on thymocyte development
Nahed El Kassar, Philip J Lucas, David B Klug, et al.
Transplantation
|
February 1, 2002
Long-term kidney graft survival across a positive historic but negative current sensitized cross-match
Christophe Baron, Myriam Pastural, Philippe Lang, et al.
Annals of the American Thoracic Society
|
October 15, 2020
Pulmonary Complications of Pediatric Hematopoietic Cell Transplantation. A National Institutes of Health Workshop Summary
Robert F Tamburro, Kenneth R Cooke, Stella M Davies, et al.
The Journal of Experimental Medicine
|
October 13, 2010
Tbata modulates thymic stromal cell proliferation and thymus function
Francis A Flomerfelt, Nahed El Kassar, Chandra Gurunathan, et al.
Research and Practice in Thrombosis and Haemostasis
|
April 26, 2024
Fewer severe infections with tranexamic acid in patients with hematologic malignancies
Jacqueline N Poston, Siobhan P Brown, Anton Ilich, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 19, 2016
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report
Juan Gea-Banacloche, Krishna V Komanduri, Paul Carpenter, et al.
Blood Advances
|
August 31, 2022
Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia
Anton Ilich, Terry B Gernsheimer, Darrell J Triulzi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Blood
|
August 26, 2004
Dynamic regulation of IL-7 receptor expression is required for normal thymopoiesis
Ivana Munitic, Joy A Williams, Yili Yang, et al.
International Immunology
|
August 18, 2012
High levels of IL-7 cause dysregulation of thymocyte development
Nahed El-Kassar, Francis A Flomerfelt, Baishakhi Choudhury, et al.
Transfusion
|
October 7, 2024
Analysis of bleeding outcomes in patients with hypoproliferative thrombocytopenia in the A-TREAT clinical trial
Jacqueline N Poston, Siobhan P Brown, Amy Sarah Ginsburg, et al.
Blood
|
May 25, 2004
A dose effect of IL-7 on thymocyte development
Nahed El Kassar, Philip J Lucas, David B Klug, et al.
Transplantation
|
February 1, 2002
Long-term kidney graft survival across a positive historic but negative current sensitized cross-match
Christophe Baron, Myriam Pastural, Philippe Lang, et al.
Annals of the American Thoracic Society
|
October 15, 2020
Pulmonary Complications of Pediatric Hematopoietic Cell Transplantation. A National Institutes of Health Workshop Summary
Robert F Tamburro, Kenneth R Cooke, Stella M Davies, et al.
The Journal of Experimental Medicine
|
October 13, 2010
Tbata modulates thymic stromal cell proliferation and thymus function
Francis A Flomerfelt, Nahed El Kassar, Chandra Gurunathan, et al.
Research and Practice in Thrombosis and Haemostasis
|
April 26, 2024
Fewer severe infections with tranexamic acid in patients with hematologic malignancies
Jacqueline N Poston, Siobhan P Brown, Anton Ilich, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 19, 2016
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report
Juan Gea-Banacloche, Krishna V Komanduri, Paul Carpenter, et al.
Blood Advances
|
August 31, 2022
Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia
Anton Ilich, Terry B Gernsheimer, Darrell J Triulzi, et al.
Page
of 2